Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Downregulation of transforming growth factor beta type II receptor in laryngeal carcinogenesis.

Journal of clinical pathology - 1 Mar 2001

Franchi A, Gallo O, Sardi I, Santucci M

Abstract excerpt

AIMS: To investigate whether anomalies of transforming growth factor beta type II receptor (TGF-beta RII) expression occur in the early stages of laryngeal carcinogenesis and to assess their importance in the development of laryngeal squamous cell carcinoma. TGF-beta RII status was examined in laryngeal premalignant lesions coupled with malignant evolution and compared with a control group of similar lesions...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Squamous Cell
Share to DNA, Neoplasm
Share to Down-Regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Laryngeal Neoplasms

Share to Neoplasm Proteins

Share to Precancerous Conditions

Share to Receptor, Transforming Growth Factor-beta Type II

Share to Receptors, Transforming Growth Factor beta

Source

Open in PubMed Open full text

Identifiers

PMID: 11253131
DOI: 10.1136/jcp.54.3.201
PMCID: PMC1731366

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Downregulation of transforming growth factor beta type II receptor in laryngeal carcinogenesis.PMID 11253131Read ↗

Decreased expression of TGF-beta cell surface receptors during progression of human oral squamous cell carcinoma.Semantic proximity Read ↗

Loss of transforming growth factor-beta type II receptor promotes metastatic head-and-neck squamous cell carcinoma.Semantic proximity Read ↗

Mechanisms of decreased expression of transforming growth factor-beta receptor type I at late stages of HPV16-mediated transformation.Semantic proximity Read ↗

Development of TGF-beta resistance during malignant progression.Semantic proximity Read ↗

Defective transforming growth factor beta signaling pathway in head and neck squamous cell carcinoma as evidenced by the lack of expression of activated Smad2.Semantic proximity Read ↗

Tumor suppressor activity of the TGF-beta pathway in human cancers.Semantic proximity Read ↗

Mutation and downregulation of the transforming growth factor beta type II receptor gene in primary squamous cell carcinomas of the head and neck.Semantic proximity Read ↗

Genetic mutation of transforming growth factor beta type II receptor in oral squamous cell carcinomaSemantic proximity Read ↗

Role of Human Papillomavirus in the Pathogenesis of Laryngeal DysplasiaSemantic proximity Read ↗

Novel inactivating mutations of transforming growth factor-beta type I receptor gene in head-and-neck cancer metastases.Semantic proximity Read ↗

Mutations and reduced expression of the transforming growth factor-beta receptor II gene in rat lung adenocarcinomas induced by N-nitrosobis-(2-hydroxypropyl)amine.Semantic proximity Read ↗

Inactivation of the transforming growth factor β type II receptor in human small cell lung cancer cell linesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.